Full text is available at the source.
Abstract
Hydroxyzine (HX) was identified as a promising scaffold for designing ionizable lipids that facilitate robust mRNA delivery to the brain.
- Analysis of over 100 CNS-active drugs led to the identification of hydroxyzine as a candidate for improving brain-targeting properties.
- HX1 liquid nanoparticles (LNPs) demonstrated effective mRNA delivery to the brain through various trafficking pathways.
- Co-delivery of CRISPR mRNA and guide RNA using HX1 LNPs enabled efficient gene editing in mouse brains.
- HX1 LNPs successfully delivered luciferase mRNA to the brain of a non-human primate.
- Carrying Il10 mRNA, HX1 LNPs reduced radiation-induced brain injury in mice, suggesting potential for preventive treatment.
Simplified